RPIA expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.896400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.234600E-01
Normal-vs-Stage2
9.798000E-01
Normal-vs-Stage3
3.453400E-01
Normal-vs-Stage4
3.457200E-01
Stage1-vs-Stage2
5.202000E-01
Stage1-vs-Stage3
3.904000E-01
Stage1-vs-Stage4
5.796200E-02
Stage2-vs-Stage3
1.862750E-01
Stage2-vs-Stage4
1.979640E-01
Stage3-vs-Stage4
3.445600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.716600E-01
Normal-vs-AfricanAmerican
7.866600E-01
Normal-vs-Asian
8.631600E-01
Caucasian-vs-AfricanAmerican
6.293800E-01
Caucasian-vs-Asian
9.525000E-01
AfricanAmerican-vs-Asian
6.292800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.752000E-01
Normal-vs-Female
9.068800E-01
Male-vs-Female
9.352400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.321800E-01
Normal-vs-Age(41-60Yrs)
8.215600E-01
Normal-vs-Age(61-80Yrs)
8.847000E-01
Normal-vs-Age(81-100Yrs)
7.237800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.942200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.761600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.485600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.829000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.072200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.165000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.779400E-01
Normal-vs-Daily Drinker
8.238200E-01
Normal-vs-Weekly Drinker
6.806200E-01
Normal-vs-Occasional Drinker
8.247600E-01
Normal-vs-Social Drinker
5.491200E-01
Non Drinker-vs-Daily Drinker
5.491400E-01
Non Drinker-vs-Weekly Drinker
4.972000E-01
Non Drinker-vs-Occasional Drinker
6.178400E-01
Non Drinker-vs-Social Drinker
3.907000E-01
Daily Drinker-vs-Weekly Drinker
3.112600E-01
Daily Drinker-vs-Occasional Drinker
8.945400E-01
Daily Drinker-vs-Social Drinker
1.839410E-01
Weekly Drinker-vs-Occasional Drinker
2.676400E-01
Weekly Drinker-vs-Social Drinker
9.024600E-01
Occasional Drinker-vs-Social Drinker
1.736200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.693200E-01
Normal-vs-Grade 2
1.681030E-01
Normal-vs-Grade 3
1.238150E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.845900E-02
Grade 1-vs-Grade 3
5.141500E-02
Grade 1-vs-Grade 4
4.693200E-01
Grade 2-vs-Grade 3
9.137600E-01
Grade 2-vs-Grade 4
1.681030E-01
Grade 3-vs-Grade 4
1.238150E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.837000E-01
Normal-vs-NonDiabetic
8.477800E-01
Diabetic-vs-NonDiabetic
5.772200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.182000E-01
Normal-vs-NoPancreatitis
8.330000E-01
Pancreatitis-vs-NoPancreatitis
4.856000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.213400E-01
Normal-vs-N1
9.701200E-01
N0-vs-N1
5.486800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.961800E-01
Normal-vs-TP53-NonMutant
8.252000E-01
TP53-Mutant-vs-TP53-NonMutant
1.053030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
